CA2140931A1 - Substituts non peptidiques pour la sequence ldv et leur utilisation dans le traitement des inflammations et des maladies auto-immunes et pour inhiber la progression des tumeurs - Google Patents

Substituts non peptidiques pour la sequence ldv et leur utilisation dans le traitement des inflammations et des maladies auto-immunes et pour inhiber la progression des tumeurs

Info

Publication number
CA2140931A1
CA2140931A1 CA002140931A CA2140931A CA2140931A1 CA 2140931 A1 CA2140931 A1 CA 2140931A1 CA 002140931 A CA002140931 A CA 002140931A CA 2140931 A CA2140931 A CA 2140931A CA 2140931 A1 CA2140931 A1 CA 2140931A1
Authority
CA
Canada
Prior art keywords
ldv
cell
compound
surrogates
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002140931A
Other languages
English (en)
Inventor
Ofer Lider
Noam Greenspoon
Rami Hershkoviz
Ronen Alon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yeda Research and Development Co Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2140931A1 publication Critical patent/CA2140931A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/60—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
CA002140931A 1992-07-26 1993-07-26 Substituts non peptidiques pour la sequence ldv et leur utilisation dans le traitement des inflammations et des maladies auto-immunes et pour inhiber la progression des tumeurs Abandoned CA2140931A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL102646 1992-07-26
IL10264692A IL102646A (en) 1992-07-26 1992-07-26 Non-peptidic surrogates of the ldv sequence and pharmaceutical compositions comprising them

Publications (1)

Publication Number Publication Date
CA2140931A1 true CA2140931A1 (fr) 1994-01-27

Family

ID=11063866

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002140931A Abandoned CA2140931A1 (fr) 1992-07-26 1993-07-26 Substituts non peptidiques pour la sequence ldv et leur utilisation dans le traitement des inflammations et des maladies auto-immunes et pour inhiber la progression des tumeurs

Country Status (6)

Country Link
EP (1) EP0652863A1 (fr)
JP (1) JPH07509469A (fr)
AU (1) AU4786093A (fr)
CA (1) CA2140931A1 (fr)
IL (1) IL102646A (fr)
WO (1) WO1994002445A1 (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6232522B1 (en) 1990-01-31 2001-05-15 Oklahoma Medical Research Foundation Non-human animal model for systemic lupus erythematosis
US6897287B1 (en) 1990-01-31 2005-05-24 Oklahoma Medical Research Foundation Ro/SSA peptide reagents for diagnosis of autoantibodies
US7888458B1 (en) 1993-11-30 2011-02-15 John B. Harley Diagnostics and therapy of epstein-barr virus in autoimmune disorders
GB9524630D0 (en) * 1994-12-24 1996-01-31 Zeneca Ltd Chemical compounds
US7001921B1 (en) 1995-01-23 2006-02-21 Biogen Idec Ma Inc. Cell adhesion inhibitors
US6306840B1 (en) 1995-01-23 2001-10-23 Biogen, Inc. Cell adhesion inhibitors
AU6311996A (en) * 1995-07-06 1997-02-05 Zeneca Limited Peptide inhibitors of fibronectine
US6248713B1 (en) 1995-07-11 2001-06-19 Biogen, Inc. Cell adhesion inhibitors
ES2133042B1 (es) * 1996-03-14 2000-05-16 Univ Valencia Politecnica Sintesis de zeolita y zeotipos isomorfos a la zeolita beta.
GB9613112D0 (en) 1996-06-21 1996-08-28 Zeneca Ltd Chemical compounds
US6239108B1 (en) 1996-07-11 2001-05-29 Biogen, Inc. Cell adhesion inhibitors
US6686350B1 (en) 1996-07-25 2004-02-03 Biogen, Inc. Cell adhesion inhibitors
ES2285735T3 (es) 1996-07-25 2007-11-16 Biogen Idec Inc Modelo molecular para inhibidores de vla-4.
US7273613B1 (en) 1997-01-13 2007-09-25 The Board of Regents, The University of Oklahoma Diagnostics and therapy of Epstein-Barr virus in autoimmune disorders
YU75500A (sh) 1998-05-28 2002-12-10 Biogen Inc. NOVI VLA-4 INHIBITORI oMePUPA-V
KR100720907B1 (ko) 1999-08-13 2007-05-25 바이오겐 아이덱 엠에이 인코포레이티드 세포 유착 억제제
US6875743B1 (en) 2000-11-28 2005-04-05 Biogen, Inc. Cell adhesion inhibitors
US7196112B2 (en) 2004-07-16 2007-03-27 Biogen Idec Ma Inc. Cell adhesion inhibitors
DE102005022845A1 (de) * 2005-05-18 2006-11-23 Fumapharm Ag Thiobernsteinsäurederivate und deren Verwendung

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL95501A (en) * 1989-09-01 1997-04-15 Hutchinson Fred Cancer Res Inhibition by antibodies of lymphocyte adherence to vascular endothelium utilizing an extracellular matrix receptor-ligand interaction, and pharmaceutical compositions containing said antibodies

Also Published As

Publication number Publication date
WO1994002445A1 (fr) 1994-02-03
JPH07509469A (ja) 1995-10-19
AU4786093A (en) 1994-02-14
IL102646A0 (en) 1993-01-14
EP0652863A1 (fr) 1995-05-17
IL102646A (en) 1996-05-14

Similar Documents

Publication Publication Date Title
JP3248584B2 (ja) フィブロネクチン接着抑制剤
CA2140931A1 (fr) Substituts non peptidiques pour la sequence ldv et leur utilisation dans le traitement des inflammations et des maladies auto-immunes et pour inhiber la progression des tumeurs
CA2393682C (fr) Depsipeptide et ses congeneres destines a etre utilises en tant qu'immunodepresseurs
US5719296A (en) Pseudopeptide lactam inhibitors of peptide binding to MHC class II proteins
US5190922A (en) Terminally modified tri-, tetra- and pentapeptide anaphylatoxin receptor ligands
BG65755B1 (bg) Инхибитори на клетъчна адхезия
CZ23299A3 (cs) Inhibitory adheze buněk a farmaceutický prostředek, který je obsahuje
JPH05504762A (ja) 抗血栓性ペプチド及び偽ペプチド
CZ359997A3 (cs) Pětičlenné heterocyklické sloučeniny jako inhibitory adheze leukocytů a antagonisté VLA-4 a farmaceutický přípravek, který je obsahuje
JPH07503944A (ja) Ａｒｇ−ｇｌｙ−ａｓｐ配列の非ペプチド代替物およびそれらからなる医薬組成物
KR20000022075A (ko) 세포 접착 억제 화합물
US6828302B1 (en) Therapeutic uses of depsipeptides and congeners thereof
JP2010209088A (ja) Ｐ−セレクチンに対する結合性化合物
CA3018344A1 (fr) Agonistes du recepteur du neuropeptide s (npsr)
JPH06506699A (ja) 抗血栓性ペプチドおよび偽ペプチド
JP2000517305A (ja) Ｎ―［ｎ―ｎ―（４―（ピペリジン―４―イル）ブタノイル）―ｎ―エチルグリシル］化合物の安定な非吸湿性結晶形
NZ242441A (en) Alpha-substituted peptides and their therapeutic use
AU703854B2 (en) Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides
GREENSPOON et al. Novel ψ‐S‐CH2 peptide‐bond replacement and its utilization in the synthesis of nonpeptidic surrogates of the Leu‐Asp‐Val sequence that exhibit specific inhibitory activities on CD4+ T cell binding to fibronectin
WO1997010261A1 (fr) Derives peptidiques
NZ299833A (en) Treating or preventing thrombosis using azacycloalkanol peptides and pseudopeptides
IL100130A (en) Guanidine derivatives and pharmaceutical compositions comprising them
JPH11503450A (ja) Ｃ−末端アミネルジックな側鎖アミノ酸残基を含む血小板凝集抑制物質

Legal Events

Date Code Title Description
FZDE Discontinued